XBONZY^® — a biosimilar by Dr. Reddy’s Biologics that expands access and supports sustainable care^{1, 3, 10, 11}

• Reliable, evidence-backed alternative² – proven efficacy and safety², comparable to the
  reference product², supported by EMA approval
  and European manufacturing^{4, 20}
• Broaden access to biologic treatment that helps reduce cost pressure on healthcare system^{1, 6, 10, 11} and supports patients with mCRPC, giving them more time till SRE progression^{8, 9}
• Dr. Reddy’s Biologics expertise – globally recognized, with 27+ years of experience in biosimilars production^{1, 5}

mCRPC: metastatic castration-resistant prostate cancer; SRE: skeletal-related events